Showing results (111-120 of 119) with videos related to
Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 119 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1996
Phase II trial of fludarabine monophosphate as first-line treatment in patients with advanced follicular lymphoma: a multicenter study by the Groupe d'Etude des Lymphomes de l'AdulteP Solal-Céligny, P Brice, N Brousse, et al.Bone Marrow Transplantation|June 14, 2006
A phase II trial of rituximab as adjuvant to intensive sequential chemotherapy in patients under 60 years with untreated poor-prognosis diffuse large B-cell lymphomaD Coso, C Sebban, O Boulat, et al.Experimental Hematology|July 25, 2000
Transplantation with selected autologous peripheral blood CD34+Thy1+ hematopoietic stem cells (HSCs) in multiple myeloma: impact of HSC dose on engraftment, safety, and immune reconstitutionM Michallet, T Philip, I Philip, et al.Leukemia|April 18, 2002
Sequential chemotherapy by CHOP and DHAP regimens followed by high-dose therapy with stem cell transplantation induces a high rate of complete response and improves event-free survival in mantle cell lymphoma: a prospective studyF Lefrère, A Delmer, F Suzan, et al.Blood|January 3, 2001
Rituximab (anti-CD20 monoclonal antibody) as single first-line therapy for patients with follicular lymphoma with a low tumor burden: clinical and molecular evaluationP Colombat, G Salles, N Brousse, et al.La Revue De Medecine Interne|March 8, 2011
[Practice guidelines of the use of bisphosphonates in solid tumours with bone metastases and in multiple myeloma]J F Brantus, C Roemer-Becuwe, P Cony-Makhoul, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 4, 2014
Outcome and prognostic factors in patients with mantle-cell lymphoma relapsing after autologous stem-cell transplantation: a retrospective study of the European Group for Blood and Marrow Transplantation (EBMT)S Dietrich, A Boumendil, H Finel, et al.Leukemia|July 30, 2013
Deletion of the 1p32 region is a major independent prognostic factor in young patients with myeloma: the IFM experience on 1195 patientsB Hebraud, X Leleu, V Lauwers-Cances, et al.Human Reproduction (Oxford, England)|December 19, 2013
Cryopreservation, semen use and the likelihood of fatherhood in male Hodgkin lymphoma survivors: an EORTC-GELA Lymphoma Group cohort studyM A E van der Kaaij, J van Echten-Arends, N Heutte, et al.Pageof 12